Ironshore Pharmaceuticals INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$7.5Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
34,229clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $3.4M
2020 $839K
2021 $410K
2022 $835K
2023 $941K
2024 $1.1M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Psychiatry $2.4M
Child & Adolescent Psychiatry $1.4M
Pediatrics $1.3M
Psychiatric/Mental Health (Nurse Practitioner) $383K
Developmental - Behavioral Pediatrics $374K
Family Medicine $193K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
James Anderson High Point, NC Pediatrics $195,164.37
Birgit Amann Troy, MI Child & Adolescent Psychiatry $186,678.84
Michael Feld Northbrook, IL Psychiatry $174,285.10
Frank Lopez Winter Park, FL Neurodevelopmental Disabilities (Pediatrics) $160,419.09
Maitri Patel Framingham, MA Child & Adolescent Psychiatry $159,396.87
Ann Childress Las Vegas, NV Child & Adolescent Psychiatry $147,795.13
George Bright Midlothian, VA Adolescent Medicine (Family Medicine) $140,972.56
Craig Kunins Gulfport, FL Child & Adolescent Psychiatry $140,226.10
Andrew Cutler Lakewood Ranch, FL Psychiatry $131,858.26
Dennis Rosen Amherst, MA Developmental - Behavioral Pediatrics $131,419.95

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.